Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...
Heat-resilient biofertilizers could help crops cope with rising temperatures but engineering them has been slow and uncertain ...
Morning Overview on MSN
New chemistry trick makes crop trait selection way easier
Plant breeders have always faced a brutal trade-off: the traits that matter most for food security, like drought tolerance or ...
RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...
Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of ...
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.
Nationwide, more than half of all states are currently experiencing very high occurrences of influenza-like illnesses, ...
Proceeds to fund clinical development of DIAG723, a first-in-class, disease-modifying therapy designed to correct the root cause of hereditary hemorrhagic telangiectasia and pulmonary arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback